Literature DB >> 8874260

Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen.

T Arita1, T Matsumoto, T Kuramitsu, M Kawamura, N Matsunaga, K Sugi, K Esato.   

Abstract

STUDY
OBJECTIVE: To reevaluate whether it is possible to reliably differentiate malignant mediastinal lymph nodes from benign nodes by size, and to determine the frequency of metastases to normal-sized mediastinal lymph nodes that directly affects the sensitivity for detecting malignant mediastinal lymph nodes (N2 nodes) on CT.
DESIGN: Prospective study of patients with non-small cell lung cancer.
SETTING: Department of Radiology and First Department of Surgery, Yamaguchi University School of Medicine. PATIENTS: We examined 40 patients with non-small cell lung cancer, who underwent thoracotomy because of operable stage (stage I, II, IIIA) in preoperative staging, using CT and transesophageal echocardiography (TEE).
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: Lymph nodes 10 mm or greater in short-axis diameter on CT and TEE were considered abnormal. Furthermore, lymph node size was measured by TEE and nodal specimens in long- and short-axis diameter in each patient. Two hundred eight mediastinal lymph nodes were dissected and N2 nodes were present in 28% of patients (11/40); in 7 of these 11 patients (64%), mediastinal lymph node metastases were misdiagnosed on CT because of normal-sized N2 nodes. Furthermore, in 73% of N2 nodes, nodal size was normal on TEE. There were no significant difference in both diameters between malignant mediastinal lymph nodes and benign nodes on TEE and nodal specimens.
CONCLUSIONS: It is not possible to reliably differentiate malignant mediastinal nodes from benign nodes by size alone, and we should be aware of high frequency of normal-sized N2 nodes in patients with operable stage of lung cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8874260     DOI: 10.1378/chest.110.4.1004

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

Review 1.  Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques.

Authors:  Christoph Frank Dietrich; Jouke Tabe Annema; Paul Clementsen; Xin Wu Cui; Mathias Maximilian Borst; Christian Jenssen
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

Review 2.  Evaluation of lymph node metastasis in lung cancer: who is the chief justice?

Authors:  Yang Xia; Bin Zhang; Hao Zhang; Wen Li; Ko-Pen Wang; Huahao Shen
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

3.  Prevalence of enlarged mediastinal lymph nodes in heavy smokers--a comparative study.

Authors:  Johannes Kirchner; Esther Maria Kirchner; Jan Peter Goltz; Vivian-Wilma Lorenz; Ralph Kickuth
Journal:  Eur Radiol       Date:  2011-04-10       Impact factor: 5.315

Review 4.  Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis.

Authors:  J-E C Holty; W G Kuschner; M K Gould
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

5.  Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer.

Authors:  Chongbiao Huang; Jie Yue; Zengxun Li; Na Li; Jinkun Zhao; Daliang Qi
Journal:  Tumour Biol       Date:  2015-04-29

6.  Relapse in resected lung cancer revisited: does intensified follow up really matter? A prospective study.

Authors:  Dragan Subotic; Dragan Mandaric; Gordana Radosavljevic; Jelena Stojsic; Milan Gajic; Maja Ercegovac
Journal:  World J Surg Oncol       Date:  2009-11-12       Impact factor: 2.754

7.  18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?

Authors:  Ruoh-Fang Yen; Ke-Cheng Chen; Jang-Ming Lee; Yeun-Chung Chang; Jane Wang; Mei-Fang Cheng; Yen-Wen Wu; Yung-Chie Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-02-19       Impact factor: 9.236

8.  Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer.

Authors:  Hajimu Gotoh; Naoki Kanomata; Masahiro Yoshimura; Yoshiharu Ohno; Takuya Moriya; Chiho Ohbayashi
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

9.  Conventional MRI to detect the differences between mass-like tuberculosis and lung cancer.

Authors:  Li-Ping Qi; Ke-Neng Chen; Xiaohong Joe Zhou; Lei Tang; Yu-Liang Liu; Xiao-Ting Li; Juan Wang; Ying-Shi Sun
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

Review 10.  Positron emission tomography scanning for the diagnosis and management of lung cancer.

Authors:  Bruce R Line; Charles S White
Journal:  Curr Treat Options Oncol       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.